Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Burlington › NPI 1538144910
Lab

Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings was paid $1.44B by Medicaid between Jan 2018 and Dec 2024, across 747 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 11% of everything it billed.

33Billing provider infoLABORATORY CORPORATION OF AMERICA HOLDINGS
BURLINGTON, NC 27215
33aNPI1538144910assigned 12/08/2005
33bProvider typeClinical Medical Laboratory
28Total paid$1.44B
24GClaims103,910,314
24DCodes billed747
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in North Carolina

Rank by total paid#1 of 128
Median peer was paid$268K
This provider vs. median5,356×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$10M$20M$30M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20189,959,220$155.06M
201911,578,910$170.88M
202014,405,415$220.36M
202117,055,238$282.07M
202217,078,258$230.39M
202317,095,906$190.49M
2024incomplete16,737,367$186.92M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 11% 1,983,525 1,689,870 $155.60M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 5.9% 3,981,823 3,529,580 $85.08M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 5.5% 3,971,406 3,519,252 $79.47M
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 5.5% 2,408,210 1,336,534 $78.50M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 5.3% 2,203,806 1,676,690 $76.26M
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 3.5% 1,359,694 1,217,713 $50.07M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 3.4% 2,757,287 2,453,362 $48.36M
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 3.1% 102,856 90,928 $44.77M
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 2.7% 550,209 455,167 $39.28M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 2.3% 683,864 470,467 $33.21M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2.2% 2,233,192 2,042,247 $31.69M
80061 Lipid panel 2.1% 4,279,588 3,936,228 $30.54M
735 more codes
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.0% 1,874,163 $29.17M
80053 Comprehensive metabolic panel 1.9% 4,808,049 $27.16M
86003 1.9% 414,345 $27.13M
84443 Thyroid stimulating hormone (TSH) 1.7% 2,741,445 $23.79M
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 1.6% 378,518 $22.89M
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 1.5% 73,374 $22.12M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.3% 4,296,335 $18.56M
83036 Hemoglobin; glycosylated (A1C) 1.2% 3,325,199 $16.52M
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1.1% 923,949 $15.35M
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1.1% 605,969 $15.27M
87536 <1% 296,900 $13.68M
87902 <1% 87,471 $12.85M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 651,421 $11.56M
80050 General health panel <1% 1,153,272 $11.43M
86480 <1% 330,285 $10.50M
87086 Culture, bacterial; quantitative colony count, urine <1% 2,104,769 $10.43M
86803 <1% 1,101,529 $8.70M
87522 Neg quan hep c or qual rna <1% 289,968 $7.49M
80081 <1% 160,830 $6.99M
84439 <1% 1,466,600 $6.80M
82607 <1% 859,016 $6.68M
80074 <1% 255,933 $6.48M
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 62,211 $6.43M
36415 Collection of venous blood by venipuncture <1% 4,419,276 $6.06M
83655 <1% 796,699 $5.95M
86235 <1% 109,025 $5.84M
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 102,554 $5.48M
82728 <1% 767,832 $5.30M
87507 <1% 34,180 $5.10M
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 65,742 $4.82M
87150 <1% 252,070 $4.64M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 24,683 $4.59M
84403 <1% 291,617 $4.21M
82746 <1% 551,831 $4.19M
87081 <1% 1,012,760 $4.07M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 101,476 $4.04M
86780 <1% 494,181 $3.98M
87340 <1% 696,568 $3.82M
86592 <1% 1,439,310 $3.80M
87529 <1% 163,215 $3.78M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 36,277 $3.62M
80055 <1% 140,785 $3.61M
85027 <1% 952,823 $3.45M
84153 <1% 362,610 $3.38M
86696 <1% 267,231 $3.32M
87186 <1% 567,597 $3.20M
86008 <1% 78,478 $3.14M
83550 <1% 695,419 $3.05M
83013 <1% 82,184 $3.03M
87088 <1% 617,458 $2.93M
86769 <1% 75,643 $2.88M
80048 Basic metabolic panel (calcium, ionized) <1% 628,883 $2.86M
87901 <1% 18,895 $2.85M
82785 <1% 254,251 $2.78M
83970 <1% 134,124 $2.70M
84702 <1% 402,493 $2.70M
83540 <1% 861,591 $2.62M
84402 <1% 178,218 $2.57M
86787 <1% 273,233 $2.49M
84146 <1% 221,095 $2.48M
86360 <1% 80,936 $2.46M
86038 <1% 335,413 $2.42M
83001 <1% 223,377 $2.33M
82570 <1% 828,925 $2.23M
82670 <1% 150,562 $2.22M
82784 <1% 269,206 $2.19M
80348 <1% 317,255 $2.18M
87077 <1% 433,549 $2.18M
88141 <1% 156,321 $2.10M
80347 <1% 170,586 $2.08M
87563 <1% 142,379 $2.08M
83516 <1% 185,867 $2.02M
87070 <1% 390,443 $2.01M
87481 <1% 76,888 $2.01M
86695 <1% 233,213 $1.90M
82043 <1% 676,488 $1.87M
80361 <1% 234,069 $1.85M
83002 <1% 179,087 $1.84M
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 13,000 $1.71M
86147 <1% 59,578 $1.68M
84481 <1% 197,777 $1.66M
81001 <1% 1,037,337 $1.65M
86706 <1% 287,703 $1.64M
83880 <1% 82,379 $1.62M
80354 <1% 255,930 $1.54M
86361 <1% 91,901 $1.53M
80358 <1% 271,185 $1.52M
81229 <1% 3,151 $1.52M
86850 <1% 233,246 $1.46M
83704 <1% 88,795 $1.44M
84436 <1% 390,617 $1.43M
80359 <1% 235,615 $1.42M
83735 <1% 396,505 $1.41M
80365 <1% 222,645 $1.40M
83021 <1% 107,010 $1.38M
80353 <1% 238,975 $1.37M
88142 <1% 105,657 $1.37M
86146 <1% 46,806 $1.36M
86762 <1% 173,717 $1.35M
87517 <1% 55,569 $1.34M
81329 <1% 43,728 $1.34M
86704 <1% 200,238 $1.33M
86376 <1% 163,757 $1.32M
80373 <1% 211,064 $1.31M
86140 <1% 460,349 $1.30M
81596 <1% 58,577 $1.29M
80372 <1% 209,523 $1.28M
82652 <1% 66,560 $1.28M
83992 <1% 159,806 $1.25M
84445 <1% 46,646 $1.20M
87900 <1% 18,173 $1.17M
83020 <1% 157,622 $1.15M
87906 <1% 15,843 $1.15M
83520 <1% 119,483 $1.14M
82950 <1% 370,470 $1.12M
80364 <1% 141,954 $1.07M
87255 <1% 53,593 $1.05M
80076 <1% 226,729 $1.04M
84480 <1% 140,813 $1.03M
80366 <1% 163,669 $1.02M
86200 <1% 129,715 $986K
80370 <1% 164,804 $971K
83993 <1% 89,251 $958K
84479 <1% 257,084 $955K
86618 <1% 82,381 $949K
87338 <1% 107,705 $934K
84144 <1% 83,483 $932K
80368 <1% 157,559 $929K
82627 <1% 78,367 $925K
80362 <1% 104,249 $918K
86160 <1% 77,879 $917K
80360 <1% 152,193 $902K
83525 <1% 133,264 $896K
86665 <1% 60,052 $891K
86225 <1% 112,291 $890K
88185 <1% 4,313 $876K
87625 <1% 33,709 $872K
84425 <1% 79,686 $860K
87535 <1% 43,638 $859K
82274 <1% 94,005 $855K
80337 <1% 142,687 $840K
80355 <1% 150,954 $833K
80326 <1% 141,913 $830K
80367 <1% 142,955 $828K
86364 <1% 119,530 $813K
80338 <1% 142,747 $808K
80334 <1% 142,590 $806K
80371 <1% 138,932 $806K
82105 <1% 90,791 $805K
80357 <1% 140,989 $796K
80377 <1% 136,645 $790K
83498 <1% 49,779 $782K
81243 <1% 25,863 $776K
86708 <1% 103,884 $774K
85652 <1% 520,981 $772K
80341 <1% 139,365 $769K
82977 <1% 229,373 $761K
82951 <1% 90,412 $758K
80344 <1% 138,799 $757K
87480 <1% 62,275 $754K
80331 <1% 138,385 $753K
84550 <1% 381,004 $743K
87660 <1% 62,008 $732K
80164 <1% 93,373 $720K
82088 <1% 30,162 $707K
86800 <1% 86,855 $700K
86256 <1% 40,643 $693K
80177 <1% 96,216 $667K
85660 <1% 173,720 $666K
86255 <1% 65,513 $665K
80346 <1% 65,991 $648K
85610 <1% 305,673 $645K
81374 <1% 16,310 $633K
83690 <1% 154,036 $628K
87521 Neg quan hep c or qual rna <1% 27,492 $619K
82248 <1% 240,391 $618K
86431 <1% 190,562 $615K
88307 <1% 4,066 $602K
87510 <1% 62,278 $574K
84207 <1% 37,036 $553K
82533 <1% 61,625 $553K
81257 <1% 6,998 $550K
82672 <1% 42,038 $544K
86317 <1% 69,142 $537K
84156 <1% 251,246 $536K
86617 <1% 36,167 $532K
83883 <1% 68,985 $525K
83921 <1% 53,967 $518K
82239 <1% 47,332 $516K
82024 <1% 24,833 $513K
86677 <1% 38,986 $513K
82172 <1% 64,855 $508K
80197 <1% 75,151 $498K
81003 <1% 424,851 $497K
88112 <1% 15,761 $492K
80324 <1% 90,806 $490K
82947 <1% 267,422 $486K
82565 <1% 238,405 $485K
84450 <1% 236,918 $485K
86757 <1% 25,667 $474K
84305 <1% 41,054 $473K
86359 <1% 18,504 $472K
85730 <1% 160,599 $472K
88342 <1% 10,949 $468K
84100 <1% 262,000 $466K
86334 <1% 38,793 $460K
83010 <1% 65,520 $458K
87650 <1% 27,236 $449K
84165 <1% 68,626 $444K
87209 <1% 45,079 $436K
84681 <1% 39,793 $429K
80069 <1% 98,810 $426K
84460 <1% 201,558 $425K
86901 <1% 210,589 $421K
82550 <1% 124,306 $420K
86900 <1% 211,448 $419K
86231 <1% 71,921 $415K
86664 <1% 43,070 $406K
0097U <1% 5,195 $401K
87075 <1% 65,019 $400K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 22,618 $395K
86258 <1% 41,775 $395K
85613 <1% 64,600 $390K
87497 <1% 20,492 $386K
83615 <1% 203,732 $380K
82150 <1% 99,773 $380K
87254 <1% 12,750 $373K
86735 <1% 50,821 $371K
84244 <1% 28,731 $366K
87427 <1% 52,986 $364K
86765 <1% 51,418 $355K
80175 <1% 45,459 $354K
84703 <1% 80,991 $346K
80159 <1% 43,180 $342K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 9,089 $338K
82247 <1% 183,631 $337K
87799 <1% 21,227 $336K
85246 <1% 25,326 $330K
81251 <1% 6,933 $329K
86705 <1% 87,755 $328K
82626 <1% 23,114 $328K
84520 <1% 207,568 $327K
82040 <1% 158,192 $327K
86341 <1% 21,737 $325K
82465 <1% 147,109 $321K
80349 <1% 55,402 $318K
85045 <1% 132,296 $317K
87581 <1% 16,034 $315K
84466 <1% 45,447 $314K
85245 <1% 24,153 $312K
85240 <1% 28,307 $306K
84630 <1% 49,877 $306K
81241 <1% 14,858 $306K
82378 <1% 35,202 $301K
82653 <1% 21,231 $301K
86870 <1% 21,979 $296K
82310 <1% 157,760 $293K
87486 <1% 14,859 $292K
84075 <1% 160,735 $292K
86747 <1% 20,933 $288K
86355 <1% 10,367 $286K
84154 <1% 33,133 $286K
85306 <1% 24,783 $283K
86037 <1% 23,663 $279K
83090 <1% 32,480 $276K
88262 <1% 4,394 $275K
81255 <1% 6,871 $274K
86141 <1% 40,671 $271K
87045 <1% 53,341 $262K
85018 <1% 195,107 $260K
82140 <1% 29,346 $260K
86671 <1% 24,742 $257K
88230 <1% 4,515 $256K
84270 <1% 22,476 $255K
87046 <1% 53,906 $255K
82525 <1% 37,817 $251K
84155 <1% 172,328 $250K
82107 <1% 7,978 $246K
87252 <1% 14,392 $242K
85732 <1% 52,898 $240K
86709 <1% 37,935 $239K
83835 <1% 23,130 $237K
87350 <1% 34,368 $235K
80178 <1% 58,767 $228K
84410 <1% 8,679 $226K
84590 <1% 37,927 $224K
83721 <1% 48,148 $223K
82157 <1% 12,991 $220K
87109 <1% 24,764 $219K
82103 <1% 28,444 $219K
81200 <1% 6,931 $217K
82164 <1% 25,292 $215K
84134 <1% 30,430 $213K
86707 <1% 28,751 $210K
87177 <1% 45,348 $208K
86702 <1% 27,769 $208K
80183 <1% 29,308 $208K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 4,031 $208K
84295 <1% 131,931 $204K
87912 <1% 1,696 $203K
82677 <1% 13,096 $203K
86644 <1% 24,708 $202K
86357 <1% 8,569 $200K
82390 <1% 33,109 $197K
85014 <1% 144,376 $197K
86645 <1% 21,439 $197K
86336 <1% 14,856 $195K
86304 <1% 21,472 $194K
88304 <1% 9,098 $194K
86593 <1% 70,165 $193K
80051 <1% 50,838 $193K
81330 <1% 6,816 $193K
84132 <1% 119,311 $190K
86381 <1% 19,625 $190K
87493 <1% 10,562 $190K
86666 <1% 12,109 $189K
83521 <1% 16,260 $187K
87101 <1% 40,013 $187K
82435 <1% 128,893 $187K
84478 <1% 72,703 $186K
86777 <1% 22,228 $185K
80299 <1% 16,344 $183K
84482 <1% 21,008 $181K
86663 <1% 18,407 $180K
84446 <1% 22,786 $177K
81401 <1% 4,843 $174K
82330 <1% 26,431 $169K
82952 <1% 67,773 $168K
G0475 Hiv antigen/antibody, combination assay, screening <1% 7,949 $166K
82384 <1% 11,051 $165K
82679 <1% 11,525 $165K
82610 <1% 19,474 $162K
85705 <1% 23,288 $161K
82139 <1% 12,276 $160K
87324 <1% 23,133 $159K
86162 <1% 13,056 $157K
87662 <1% 3,776 $157K
82175 <1% 12,487 $156K
86015 <1% 22,125 $156K
80321 <1% 17,953 $155K
81240 <1% 10,493 $155K
80356 <1% 16,104 $153K
86694 <1% 17,721 $152K
86300 <1% 18,052 $149K
85598 <1% 16,465 $145K
88341 <1% 2,649 $145K
85303 <1% 18,385 $144K
83718 <1% 33,488 $144K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 16,080 $143K
87538 <1% 7,151 $143K
88189 <1% 3,718 $141K
83519 <1% 13,656 $141K
85060 <1% 17,340 $141K
84238 <1% 6,136 $137K
80156 <1% 15,596 $137K
84166 <1% 13,775 $134K
86005 <1% 23,486 $130K
85379 <1% 25,423 $129K
87905 <1% 15,290 $127K
83825 <1% 13,093 $126K
86701 <1% 23,440 $123K
80165 <1% 17,204 $123K
82397 <1% 17,764 $122K
82787 <1% 9,989 $121K
86738 <1% 10,452 $121K
85300 <1% 18,231 $120K
81256 <1% 3,980 $120K
82085 <1% 21,527 $120K
86301 <1% 12,477 $119K
84432 <1% 14,102 $118K
82530 <1% 11,293 $118K
86778 <1% 14,117 $117K
80185 <1% 14,720 $116K
82985 <1% 15,286 $116K
81242 <1% 6,847 $115K
85670 <1% 36,541 $115K
87102 <1% 18,917 $114K
86335 <1% 8,070 $112K
86356 <1% 6,310 $111K
81361 <1% 6,450 $111K
87184 <1% 24,545 $109K
80235 <1% 11,017 $107K
81290 <1% 6,764 $105K
81260 <1% 6,787 $105K
87329 <1% 16,065 $105K
81479 Unlisted molecular pathology procedure <1% 1,676 $103K
85041 <1% 49,452 $102K
81025 <1% 24,752 $101K
84080 <1% 12,763 $101K
85305 <1% 14,686 $100K
86060 <1% 22,758 $100K
82300 <1% 7,155 $98K
88184 <1% 4,164 $97K
85004 <1% 21,189 $95K
82668 <1% 10,890 $95K
83631 <1% 10,519 $93K
0099U <1% 1,019 $91K
80374 <1% 10,535 $90K
83695 <1% 15,139 $89K
86794 <1% 8,242 $89K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 7,306 $87K
85048 <1% 51,061 $87K
81377 <1% 1,512 $86K
88312 <1% 2,016 $84K
85302 <1% 12,354 $84K
87476 <1% 4,570 $83K
86753 <1% 7,231 $82K
86682 <1% 9,768 $81K
82955 <1% 14,567 $80K
80171 <1% 8,809 $79K
84255 <1% 6,738 $78K
81206 <1% 1,419 $78K
87999 <1% 3,003 $77K
80201 <1% 11,634 $77K
80323 <1% 6,565 $77K
81209 <1% 6,895 $76K
83003 <1% 5,705 $76K
81381 <1% 2,417 $74K
81291 <1% 5,940 $74K
82232 <1% 9,394 $72K
86658 <1% 3,369 $72K
81207 <1% 1,418 $71K
87593 <1% 2,986 $70K
81270 <1% 1,961 $69K
84597 <1% 8,668 $69K
86340 <1% 8,586 $68K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 15,017 $67K
82731 <1% 2,180 $67K
82379 <1% 7,196 $67K
83789 <1% 6,509 $66K
86606 <1% 6,423 $66K
83014 <1% 18,444 $65K
80184 <1% 9,741 $63K
87106 <1% 9,759 $62K
87496 <1% 3,370 $61K
84484 <1% 9,748 $61K
86337 <1% 5,147 $60K
82104 <1% 7,646 $60K
86615 <1% 3,977 $58K
85301 <1% 9,061 $56K
82507 <1% 3,647 $56K
80202 <1% 7,617 $55K
80203 <1% 7,204 $55K
82017 <1% 5,442 $55K
86148 <1% 5,453 $54K
87040 <1% 8,948 $54K
85597 <1% 5,364 $53K
86215 <1% 6,663 $53K
83605 <1% 7,785 $53K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,006 $51K
84252 <1% 4,740 $51K
82180 <1% 9,176 $50K
83919 <1% 5,162 $50K
82374 <1% 30,699 $49K
87205 <1% 18,954 $48K
82552 <1% 5,729 $48K
86316 <1% 5,346 $47K
86161 <1% 5,435 $47K
84260 <1% 3,747 $47K
82542 <1% 4,974 $47K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 3,068 $47K
81490 <1% 1,213 $46K
82553 <1% 7,112 $46K
87328 <1% 6,269 $45K
81517 <1% 711 $45K
82747 <1% 6,137 $44K
80158 <1% 4,613 $43K
82308 <1% 3,030 $42K
86308 <1% 13,337 $42K
80325 <1% 4,906 $42K
83935 <1% 11,610 $42K
85384 <1% 8,592 $40K
84152 <1% 3,845 $40K
80195 <1% 6,020 $39K
81500 <1% 1,092 $39K
87206 <1% 12,545 $38K
83088 <1% 2,169 $38K
83527 <1% 5,293 $37K
87631 <1% 608 $37K
84163 <1% 4,528 $37K
82166 <1% 3,712 $36K
82360 <1% 4,226 $36K
82656 <1% 5,064 $35K
85250 <1% 3,245 $35K
82575 <1% 5,637 $35K
82941 <1% 3,538 $33K
81279 <1% 735 $33K
84585 <1% 3,707 $33K
82340 <1% 9,657 $33K
85007 <1% 18,506 $32K
81338 <1% 740 $32K
87230 <1% 2,625 $32K
81332 <1% 1,674 $32K
88173 <1% 851 $32K
82131 <1% 3,238 $32K
83930 <1% 8,650 $31K
87210 <1% 11,813 $30K
84591 <1% 4,865 $30K
80186 <1% 4,265 $29K
85520 <1% 3,488 $29K
89055 <1% 10,978 $28K
83497 <1% 4,072 $28K
84145 <1% 2,512 $28K
86051 <1% 1,662 $28K
86366 <1% 606 $27K
83945 <1% 3,841 $27K
85307 <1% 3,137 $26K
87634 <1% 764 $26K
86362 <1% 1,433 $26K
81219 <1% 828 $26K
85270 <1% 2,676 $26K
86631 <1% 3,916 $26K
86036 <1% 7,101 $26K
86041 <1% 1,554 $26K
80162 <1% 3,776 $26K
81383 <1% 628 $26K
82523 <1% 3,742 $25K
87505 <1% 359 $25K
85049 <1% 10,129 $25K
84120 <1% 2,381 $25K
87899 <1% 3,193 $24K
82705 <1% 8,282 $24K
80180 <1% 2,911 $24K
86804 <1% 2,258 $23K
87076 <1% 4,653 $23K
85247 <1% 1,830 $23K
85220 <1% 2,305 $23K
86602 <1% 2,732 $23K
84300 <1% 8,478 $23K
84140 <1% 1,804 $22K
84206 <1% 1,818 $22K
G0124 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician <1% 2,577 $22K
86609 <1% 2,596 $22K
87110 <1% 1,583 $21K
88237 <1% 489 $21K
87116 <1% 3,950 $20K
82642 <1% 1,418 $20K
87260 <1% 2,509 $20K
83874 <1% 3,092 $20K
80168 <1% 1,990 $20K
86042 <1% 1,329 $20K
87299 <1% 2,441 $19K
87641 <1% 908 $19K
83698 <1% 1,620 $19K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 172 $19K
86022 <1% 2,014 $19K
86331 <1% 2,556 $19K
81403 <1% 271 $19K
85549 <1% 1,798 $19K
87279 <1% 2,436 $19K
84588 <1% 1,142 $19K
87280 <1% 2,499 $18K
87468 <1% 1,122 $18K
87276 <1% 2,410 $18K
86305 <1% 1,973 $18K
85397 <1% 1,358 $18K
84143 <1% 1,471 $18K
85385 <1% 3,077 $18K
81422 <1% 270 $18K
87275 <1% 2,443 $18K
G0307 Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) <1% 13,618 $18K
84202 <1% 2,072 $18K
85415 <1% 2,412 $18K
82108 <1% 965 $18K
80332 <1% 5,000 $17K
82375 <1% 2,343 $17K
84442 <1% 2,137 $17K
81015 <1% 8,112 $17K
82681 <1% 1,401 $17K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 2,241 $17K
85280 <1% 1,617 $16K
80157 <1% 2,380 $16K
87015 <1% 4,860 $16K
87425 <1% 2,255 $16K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 5,244 $16K
89060 <1% 2,802 $16K
86880 <1% 5,644 $16K
80145 <1% 1,320 $15K
80169 <1% 1,969 $15K
80320 <1% 2,038 $15K
86043 <1% 1,220 $15K
81599 <1% 799 $13K
82595 <1% 3,440 $13K
86790 <1% 2,102 $13K
80363 <1% 1,427 $13K
84378 <1% 2,314 $12K
80173 <1% 1,681 $12K
86710 <1% 949 $12K
84433 <1% 517 $12K
82657 <1% 1,123 $12K
81402 <1% 184 $11K
83937 <1% 836 $11K
87469 <1% 507 $11K
85230 <1% 1,248 $11K
86788 <1% 921 $11K
80345 <1% 2,876 $11K
80230 <1% 1,236 $10K
G0306 Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count <1% 10,835 $10K
84133 <1% 4,102 $10K
86612 <1% 1,420 $10K
0014M <1% 227 $10K
88289 <1% 617 $10K
0003M <1% 524 $10K
88271 <1% 538 $10K
87807 <1% 1,479 $10K
86596 <1% 1,264 $10K
87420 <1% 1,500 $10K
86698 <1% 1,226 $9K
86622 <1% 1,102 $9K
80188 <1% 1,857 $9K
84181 <1% 833 $9K
83915 <1% 1,370 $9K
87484 <1% 533 $9K
85260 <1% 913 $9K
83625 <1% 1,421 $9K
86789 <1% 909 $9K
80179 <1% 1,258 $9K
85210 <1% 1,348 $9K
82540 <1% 3,083 $9K
82436 <1% 3,027 $8K
88275 <1% 437 $8K
82380 <1% 1,496 $8K
87449 <1% 1,482 $8K
80339 <1% 1,230 $8K
84560 <1% 3,194 $8K
84105 <1% 2,989 $8K
82373 <1% 819 $8K
89051 <1% 2,643 $8K
84586 <1% 491 $8K
87467 <1% 297 $8K
99199 Unlisted special service, procedure or report <1% 1,437 $8K
86332 <1% 560 $7K
84392 <1% 2,676 $7K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 790 $7K
86849 <1% 1,132 $7K
99001 <1% 10,253 $7K
86226 <1% 855 $6K
87140 <1% 1,583 $6K
82136 <1% 690 $6K
83986 <1% 2,719 $6K
84110 <1% 1,083 $5K
80414 <1% 224 $5K
83785 <1% 410 $5K
83529 <1% 908 $5K
80143 <1% 493 $5K
86052 <1% 322 $5K
87498 <1% 158 $5K
83951 <1% 148 $4K
86001 <1% 257 $4K
88311 <1% 640 $4K
80375 <1% 903 $4K
81244 <1% 469 $4K
88300 <1% 444 $4K
87207 <1% 1,025 $4K
86635 <1% 573 $4K
82495 <1% 344 $3K
99499 <1% 105 $3K
82608 <1% 303 $3K
82710 <1% 332 $3K
85635 <1% 632 $3K
86638 <1% 438 $3K
84999 <1% 480 $3K
85611 <1% 1,008 $3K
86611 <1% 323 $3K
83918 <1% 309 $3K
87305 <1% 443 $3K
88302 <1% 243 $3K
82010 <1% 615 $2K
85420 <1% 605 $2K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 91 $2K
87556 <1% 151 $2K
80503 <1% 73 $2K
86039 <1% 40 $2K
86906 <1% 365 $2K
80342 <1% 173 $2K
87471 <1% 96 $2K
0001M <1% 33 $2K
0024U <1% 761 $1K
80285 <1% 60 $1K
80167 <1% 158 $1K
86905 <1% 365 $1K
83018 <1% 93 $1K
80220 <1% 781 $1K
80369 <1% 317 $1K
83150 <1% 84 $1K
81375 <1% 14 $971.45
89321 <1% 209 $917.64
87808 <1% 69 $832.96
86703 <1% 98 $814.44
83916 <1% 52 $805.62
88313 <1% 31 $804.60
85810 <1% 167 $784.58
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 30 $781.63
87169 <1% 285 $716.75
81002 <1% 360 $712.37
84066 <1% 140 $649.13
82945 <1% 289 $641.98
86603 <1% 58 $615.64
81327 <1% 37 $598.91
36416 <1% 4,901 $593.30
87253 <1% 55 $560.15
82777 <1% 96 $536.50
82725 <1% 61 $479.69
80335 <1% 45 $442.48
87385 <1% 73 $421.25
84157 <1% 168 $409.92
84210 <1% 52 $401.68
85291 <1% 99 $376.82
80210 <1% 39 $355.34
82042 <1% 40 $316.90
84182 <1% 15 $292.18
80198 <1% 33 $277.73
80280 <1% 25 $264.11
88187 <1% 12 $238.31
84449 <1% 40 $236.98
86157 <1% 58 $231.57
86352 <1% 15 $230.06
84376 <1% 96 $215.96
86632 <1% 41 $215.77
87168 <1% 68 $208.91
86713 <1% 24 $189.48
88164 <1% 30 $184.76
87172 <1% 78 $177.14
84540 <1% 79 $176.01
82135 <1% 12 $120.43
80189 <1% 12 $108.75
86628 <1% 33 $86.17
S3600 Stat laboratory request (situations other than s3601) <1% 1,031 $46.23
82365 <1% 13 $44.16
82978 <1% 14 $43.30
80376 <1% 535 $21.87
INVCD 0% 15 $0.00
81415 0% 52 $0.00
99080 0% 191 $0.00
80305 0% 68 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VP)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →
ProviderLocationPaid
Laboratory Corporation of America HoldingsRaritan, NJ$717.47M
Laboratory Corporation of America HoldingsDublin, OH$617.02M
Laboratory Corporation of America HoldingsBirmingham, AL$289.12M
Laboratory Corporation of AmericaPhoenix, AZ$265.90M
Laboratory Corporation of America HoldingsBurlington, NC$264.26M
Laboratory Corporation of America HoldingsCharleston, WV$220.04M
Laboratory Corporation of AmericaSeattle, WA$186.69M
Laboratory Corporation of AmericaTampa, FL$171.13M
Laboratory Corporation of AmericaSan Diego, CA$147.14M
Laboratory Corporation of AmericaHouston, TX$103.81M
Laboratory Corporation of AmericaEnglewood, CO$77.80M
Laboratory Corporation of AmericaDallas, TX$77.42M
Laboratory Corporation of AmericaBurlington, NC$59.75M
Medtox Laboratories, INCSaint Paul, MN$47.72M
Laboratory Corporation of America HoldingsBurlington, NC$15.65M
Laboratory Corporation of AmericaSan Antonio, TX$11.67M
Tri-Cities Laboratory, LLCKennewick, WA$8.69M
Laboratory Corporation of America HoldingsMonroe, LA$3.39M
Laboratory Corporation of AmericaItasca, IL$3.37M
Laboratory Corporation of AmericaAlbany, NY$2.06M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.